These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 19945008)

  • 1. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Rubin M; Dover J; Maas C; Nestor M
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S50-6. PubMed ID: 19945005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Baumann L; Brandt FS; Kane MA; Donofrio LM
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S57-65. PubMed ID: 19945006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
    Wortzman MS; Pickett A
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Cohen JL; Schlessinger J; Cox SE; Lin X;
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S43-9. PubMed ID: 19945004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of neutralizing antibody induction during treatment of glabellar lines with a new US formulation of botulinum neurotoxin type A.
    Lawrence I; Moy R
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S66-71. PubMed ID: 19945007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A.
    Schlessinger J; Monheit G; Kane MA; Mendelsohn N
    Dermatol Surg; 2011 Oct; 37(10):1434-42. PubMed ID: 21745254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
    Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC
    J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
    Kane M; Donofrio L; Ascher B; Hexsel D; Monheit G; Rzany B; Weiss R
    J Drugs Dermatol; 2010 Jan; 9(1 Suppl):s7-22; quiz s23-5. PubMed ID: 20919448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical applications of a new botulinum toxin.
    Hexsel D; Spencer JM; Woolery-Lloyd H; Gilbert E
    J Drugs Dermatol; 2010 Mar; 9(3 Suppl):s31-7. PubMed ID: 20361474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DaxibotulinumtoxinA-lanm (Daxxify™): A Comprehensive Overview.
    Salame N; Eber AE; Dover J
    Skin Therapy Lett; 2023 Jul; 28(4):1-3. PubMed ID: 37440610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
    Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
    Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
    Lorenc ZP; Smith S; Nestor M; Nelson D; Moradi A
    Aesthetic Plast Surg; 2013 Oct; 37(5):975-83. PubMed ID: 23846022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cosmetic botulinum toxin: has it replaced more invasive facial procedures?
    Loyo M; Kontis TC
    Facial Plast Surg Clin North Am; 2013 May; 21(2):285-98. PubMed ID: 23731589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consideration of muscle mass in glabellar line treatment with botulinum toxin type A.
    Monheit G; Lin X; Nelson D; Kane M
    J Drugs Dermatol; 2012 Sep; 11(9):1041-5. PubMed ID: 23135645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
    Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.